List of Vertex Pharmaceuticals patents

Patents where

Current Assignee

Name

Vertex Pharmaceuticals

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 8119631 Inhibitors of interleukin-1β converting enzyme	Patent 8119631 was granted and assigned to Vertex Pharmaceuticals on February, 2012 by the United States Patent and Trademark Office.		Vertex Pharmaceuticals	United States Patent and Trademark Office	8119631	February 21, 2012
‌ US Patent 7820671 Peptidomimetic protease inhibitors	Patent 7820671 was granted and assigned to Vertex Pharmaceuticals on October, 2010 by the United States Patent and Trademark Office.		Vertex Pharmaceuticals	United States Patent and Trademark Office	7820671	October 26, 2010
‌ US Patent 8252923 Peptidomimetic protease inhibitors	Patent 8252923 was granted and assigned to Vertex Pharmaceuticals on August, 2012 by the United States Patent and Trademark Office.		Vertex Pharmaceuticals	United States Patent and Trademark Office	8252923	August 28, 2012
‌ US Patent 9340546 Compounds useful as inhibitors of ATR kinase	Patent 9340546 was granted and assigned to Vertex Pharmaceuticals on May, 2016 by the United States Patent and Trademark Office.	Vertex Pharmaceuticals	Vertex Pharmaceuticals	United States Patent and Trademark Office	9340546	May 17, 2016
‌ US Patent 11052075 Pharmaceutical compositions of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl) benzoic acid and administration thereof	Patent 11052075 was granted and assigned to Vertex Pharmaceuticals on July, 2021 by the United States Patent and Trademark Office.	Vertex Pharmaceuticals	Vertex Pharmaceuticals	United States Patent and Trademark Office	11052075	July 6, 2021
‌ US Patent 10980746 Pharmaceutical compositions for the treatment of cystic fibrosis transmembrane conductance regulator mediated diseases	Patent 10980746 was granted and assigned to Vertex Pharmaceuticals on April, 2021 by the United States Patent and Trademark Office.	Vertex Pharmaceuticals	Vertex Pharmaceuticals	United States Patent and Trademark Office	10980746	April 20, 2021
‌ US Patent 7790713 Inhibitors of interleukin-1β converting enzyme	Patent 7790713 was granted and assigned to Vertex Pharmaceuticals on September, 2010 by the United States Patent and Trademark Office.		Vertex Pharmaceuticals	United States Patent and Trademark Office	7790713	September 7, 2010
‌ US Patent 8455497 Inhibitors of aspartyl protease	Patent 8455497 was granted and assigned to Vertex Pharmaceuticals on June, 2013 by the United States Patent and Trademark Office.		Vertex Pharmaceuticals	United States Patent and Trademark Office	8455497	June 4, 2013
‌ US Patent 7216041 Methods of using the structure coordinates of molecules comprising an IMPDH-like binding pocket	Patent 7216041 was granted and assigned to Vertex Pharmaceuticals on May, 2007 by the United States Patent and Trademark Office.		Vertex Pharmaceuticals	United States Patent and Trademark Office	7216041	May 8, 2007
‌ US Patent 7527952 Crystals of inosine monophosphate dehydrogenase/oxidized inosine monophosphate thiomidate intermediate/mycophenolic acid (IIMPDH/XMP*/MPA)	Patent 7527952 was granted and assigned to Vertex Pharmaceuticals on May, 2009 by the United States Patent and Trademark Office.		Vertex Pharmaceuticals	United States Patent and Trademark Office	7527952	May 5, 2009
‌ US Patent 10058546 Pharmaceutical compositions of (R)-1-(2,2-difluorobenzo[D][1,3]dioxo1-5-y1)-N-(1-(2,3-dihydroxypropy1)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-y1)-1H-indol-5-y1) cyclopropanecarbox-amide and administration thereof	Patent 10058546 was granted and assigned to Vertex Pharmaceuticals on August, 2018 by the United States Patent and Trademark Office.	Vertex Pharmaceuticals	Vertex Pharmaceuticals	United States Patent and Trademark Office	10058546	August 28, 2018
‌ US Patent 10039762 Inhibitors of influenza viruses replication	Patent 10039762 was granted and assigned to Vertex Pharmaceuticals on August, 2018 by the United States Patent and Trademark Office.	Vertex Pharmaceuticals	Vertex Pharmaceuticals	United States Patent and Trademark Office	10039762	August 7, 2018
‌ US Patent 10206877 Pharmaceutical compositions for the treatment of cystic fibrosis transmembrane conductance regulator mediated diseases	Patent 10206877 was granted and assigned to Vertex Pharmaceuticals on February, 2019 by the United States Patent and Trademark Office.	Vertex Pharmaceuticals	Vertex Pharmaceuticals	United States Patent and Trademark Office	10206877	February 19, 2019
‌ US Patent 7390808 Inhibitors of GSK-3 and crystal structures of GSK-3β protein and protein complexes	Patent 7390808 was granted and assigned to Vertex Pharmaceuticals on June, 2008 by the United States Patent and Trademark Office.		Vertex Pharmaceuticals	United States Patent and Trademark Office	7390808	June 24, 2008
‌ US Patent 10272046 Pharmaceutical composition and administrations thereof	Patent 10272046 was granted and assigned to Vertex Pharmaceuticals on April, 2019 by the United States Patent and Trademark Office.	Vertex Pharmaceuticals	Vertex Pharmaceuticals	United States Patent and Trademark Office	10272046	April 30, 2019
‌ US Patent 9701674 Substituted pyrazines as ATR kinase inhibitors	Patent 9701674 was granted and assigned to Vertex Pharmaceuticals on July, 2017 by the United States Patent and Trademark Office.	Vertex Pharmaceuticals	Vertex Pharmaceuticals	United States Patent and Trademark Office	9701674	July 11, 2017
‌ US Patent 9365557 Substituted pyrazin-2-amines as inhibitors of ATR kinase	Patent 9365557 was granted and assigned to Vertex Pharmaceuticals on June, 2016 by the United States Patent and Trademark Office.	Vertex Pharmaceuticals	Vertex Pharmaceuticals	United States Patent and Trademark Office	9365557	June 14, 2016
‌ US Patent 11639347 Modulators of ATP-binding cassette transporters	Patent 11639347 was granted and assigned to Vertex Pharmaceuticals on May, 2023 by the United States Patent and Trademark Office.	Vertex Pharmaceuticals	Vertex Pharmaceuticals	United States Patent and Trademark Office	11639347	May 2, 2023
‌ US Patent 10239867 Modulators of ATP-binding cassette transporters	Patent 10239867 was granted and assigned to Vertex Pharmaceuticals on March, 2019 by the United States Patent and Trademark Office.	Vertex Pharmaceuticals	Vertex Pharmaceuticals	United States Patent and Trademark Office	10239867	March 26, 2019
‌ US Patent 10022352 Modulators of ATP-binding cassette transporters	Patent 10022352 was granted and assigned to Vertex Pharmaceuticals on July, 2018 by the United States Patent and Trademark Office.	Vertex Pharmaceuticals	Vertex Pharmaceuticals	United States Patent and Trademark Office	10022352	July 17, 2018
‌ US Patent 7452873 Inhibitors of GSK-3 and uses thereof	Patent 7452873 was granted and assigned to Vertex Pharmaceuticals on November, 2008 by the United States Patent and Trademark Office.		Vertex Pharmaceuticals	United States Patent and Trademark Office	7452873	November 18, 2008
‌ US Patent 7494988 Inhibitors of serine proteases, particularly hepatitis C virus NS3 protease	Patent 7494988 was granted and assigned to Vertex Pharmaceuticals on February, 2009 by the United States Patent and Trademark Office.		Vertex Pharmaceuticals	United States Patent and Trademark Office	7494988	February 24, 2009
‌ US Patent 7288624 Inhibitors of interleukin-1β converting enzyme	Patent 7288624 was granted and assigned to Vertex Pharmaceuticals on October, 2007 by the United States Patent and Trademark Office.		Vertex Pharmaceuticals	United States Patent and Trademark Office	7288624	October 30, 2007
‌ US Patent 7772366 Inhibitors of interleukin-1β converting enzyme	Patent 7772366 was granted and assigned to Vertex Pharmaceuticals on August, 2010 by the United States Patent and Trademark Office.		Vertex Pharmaceuticals	United States Patent and Trademark Office	7772366	August 10, 2010
‌ US Patent 9309250 Substituted pyrrolo[2,3-b]pyrazines as ATR kinase inhibitors	Patent 9309250 was granted and assigned to Vertex Pharmaceuticals on April, 2016 by the United States Patent and Trademark Office.		Vertex Pharmaceuticals	United States Patent and Trademark Office	9309250	April 12, 2016

...

Results per page:

899 results

0 selected

899 results

0 selected